J L Pico
Overview
Explore the profile of J L Pico including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
938
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Massard C, Kramar A, Beyer J, Hartmann J, Lorch A, Pico J, et al.
Ann Oncol
. 2012 Oct;
24(2):322-328.
PMID: 23104726
Background: An early serum tumor marker (TM) decline during chemotherapy was shown to independently predict survival in patients with poor-prognosis disseminated non-seminomatous germ-cell tumors (NSGCTs). The aim of this study...
2.
Ulusakarya A, Chachaty E, Vantelon J, Youssef A, Tancrede C, Pico J, et al.
Hematol J
. 2002 Mar;
1(2):111-6.
PMID: 11920178
Introduction: The incidence of invasive fungal infections is increasing in patients with hematological malignancies. Invasive aspergillosis is one of the most frequently encountered infections with a high mortality rate. New...
3.
Lhomme C, Brault P, Bourhis J, Pautier P, Dohollou N, Dietrich P, et al.
Leuk Lymphoma
. 2001 Nov;
42(5):1033-41.
PMID: 11697620
Vaginal bleeding during aplasia can induce transfusion support, infection and discomfort. Oral and intramuscular hormonotherapy can be toxic and/or difficult to manage (mucositis). This single-center pilot study evaluated the efficacy...
4.
Castagna L, Benhamou E, PEDRAZA E, Luboinski M, Forni M, Brandes I, et al.
Ann Oncol
. 2001 Aug;
12(7):953-5.
PMID: 11521801
Mucositis is still a leading side effect of high dose chemotherapy and irradiation delivered in autologous and allogeneic bone marrow transplantation. In this double blind randomised study, we tested the...
5.
Vantelon J, Munck J, Bourhis J, Pico J, Fadel C, Ulusakarya A, et al.
Bone Marrow Transplant
. 2001 Apr;
27(5):531-6.
PMID: 11313688
Ten patients with refractory (n = 8) or early relapsing (n = 2) aggressive non-Hodgkin's lymphoma were enrolled in a pilot study evaluating a high-dose sequential chemotherapy regimen with peripheral...
6.
Blaise D, Attal M, Reiffers J, Michallet M, Bellanger C, Pico J, et al.
Eur Cytokine Netw
. 2000 Mar;
11(1):91-8.
PMID: 10705305
Immunological control of acute leukemia may be achieved after allogeneic transplant. Despite promising preliminary results, the impact of immunotherapy with interleukin-2 (r-IL-2) on patients with acute leukemia (AL), in first...
7.
Girinsky T, Benhamou E, Bourhis J, Dhermain F, Ganansia V, Luboinski M, et al.
J Clin Oncol
. 2000 Mar;
18(5):981-6.
PMID: 10694547
Purpose: Fractionated total-body irradiation (HTBI) is considered to induce less toxicity to normal tissues and probably has the same efficacy as single-dose total-body irradiation (STBI) in patients with acute myeloid...
8.
Michallet M, Tanguy M, Socie G, Thiebaut A, Belhabri A, Milpied N, et al.
Br J Haematol
. 2000 Feb;
108(2):400-7.
PMID: 10691873
Although recurrent malignancy is the most frequent indication for second stem cell transplantation (2nd SCT), there are few reports that include sufficiently large numbers of patients to enable prognostic factor...
9.
Turhan A, Bourhis J, Bonnet M, Novault S, Bayle C, Bennaceur A, et al.
Hematol Cell Ther
. 2000 Jan;
41(5):197-204.
PMID: 10651119
CD(34+)-enriched peripheral blood stem cells (PBSC) are increasingly being used as an autograft in patients with multiple myeloma (MM). The rationale for the use of the CD34+-enriched fraction in MM...
10.
Ulusakarya A, Lumbroso J, Casiraghi O, Koscielny S, Vantelon J, Girinsky T, et al.
Leuk Lymphoma
. 1999 Dec;
35(5-6):579-86.
PMID: 10609795
Optimal evaluation of residual masses of non Hodgkin's lymphomas (NHL) after chemotherapy is of major importance, and gallium scan (GS) is routinely used for this purpose, particularly for mediastinal sites....